Navigation Links
Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
Date:9/23/2010

n of large scale M&A 'plays' by Pfizer 9

Diversification strategy at heart of Wyeth M&A 11

Outlook - will Pfizer return to the M&A trail before 2015? 16

SWOT analysis 19

Table of Contents 20

Table of figures 22

Chapter 3 Quarterly news update 23

Latest quarterly sales 23

Latest comment 24

Hope for an Alzheimer's breakthrough remains despite Dimebon's failure 24

Pfizer's novel NGF pain drug is potential game changer 25

Pfizer: Lyrica sNDA withdrawal no cause for anxiety 26

Latest prescription pharma product news 27

Q4 2009 29

Q3 2009 32

Q1 2009 33

Latest corporate news 35

Q1 2010 35

Q4 2009 35

Q3 2009 36

Q2 2009 36

Q1 2009 37

Future product milestones 39

Chapter 4 Company introduction 41

Key findings 41

Background 42

Key corporate developments 42

M&A history 42

Warner-Lambert acquisition 43

Pharmacia acquisition 43

Chapter 5 Company sales 46

Key findings 46

Prescription pharmaceutical sales and growth rate analysis, 2003-15 47

Product analysis 49

Product analysis, 2003-09 50

Product analysis, 2009-15 53

Therapy area analysis 56

Geographic analysis 59

Launch/core/expiry analysis 60

Explanation of launch/core/expiry analysis 60

Launch analysis, 2009-15 61

Core analysis, 2009-15 63

Expiry analysis, 2009-15 64

Launch/core/expiry configuration, 2009-15 66

Molecule type analysis 69

Externalization analysis 71

Chapter 6 Company financials 73

Key findings 73

Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08 74

Operating costs and profit analysis 75

Operating costs and profit analysis, 2002-08 76

Operating cost ratio and profit margin analysis, 200
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... discover technological and commercial prospects What does ... market? Visiongain,s brand new report shows you ...
(Date:8/28/2014)... -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – ... - http://photos.prnewswire.com/prnh/20140828/140879 ) The ... Poland " an essential source of information and ... and provides insights into the demographic, regulatory, reimbursement ... provides valuable insights into the trends and segmentation ...
(Date:8/28/2014)... 2014  Decision Resources Group finds that the market for ... billion by 2023 in the United States ... , Italy , Spain ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin ... by the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2
... DUBLIN, October 30 Shire plc (LSE: SHP, NASDAQ:,SHPGY) the global specialty biopharmaceutical company, announces results for,the three months to September ... ... Q3 2009(1), Product sales ... million -15%, Product sales from core products(2) ...
... TAIPEI, Taiwan, Oct. 30 ... in Beijing: from bench to bedside and community, ... This solution entails a series of,innovative professional ... diagnosis, and treatment follow-up. Microlife successfully,developed several ...
Cached Medicine Technology:Shire Continues to Deliver Excellent Growth From Core Products 2Shire Continues to Deliver Excellent Growth From Core Products 3Shire Continues to Deliver Excellent Growth From Core Products 4Shire Continues to Deliver Excellent Growth From Core Products 5Shire Continues to Deliver Excellent Growth From Core Products 6Shire Continues to Deliver Excellent Growth From Core Products 7Shire Continues to Deliver Excellent Growth From Core Products 8Shire Continues to Deliver Excellent Growth From Core Products 9Shire Continues to Deliver Excellent Growth From Core Products 10Shire Continues to Deliver Excellent Growth From Core Products 11Shire Continues to Deliver Excellent Growth From Core Products 12Shire Continues to Deliver Excellent Growth From Core Products 13Shire Continues to Deliver Excellent Growth From Core Products 14Shire Continues to Deliver Excellent Growth From Core Products 15Shire Continues to Deliver Excellent Growth From Core Products 16Shire Continues to Deliver Excellent Growth From Core Products 17Shire Continues to Deliver Excellent Growth From Core Products 18Shire Continues to Deliver Excellent Growth From Core Products 19Shire Continues to Deliver Excellent Growth From Core Products 20Shire Continues to Deliver Excellent Growth From Core Products 21Shire Continues to Deliver Excellent Growth From Core Products 22Shire Continues to Deliver Excellent Growth From Core Products 23Shire Continues to Deliver Excellent Growth From Core Products 24Shire Continues to Deliver Excellent Growth From Core Products 25Shire Continues to Deliver Excellent Growth From Core Products 26Shire Continues to Deliver Excellent Growth From Core Products 27Shire Continues to Deliver Excellent Growth From Core Products 28Shire Continues to Deliver Excellent Growth From Core Products 29Shire Continues to Deliver Excellent Growth From Core Products 30Shire Continues to Deliver Excellent Growth From Core Products 31Shire Continues to Deliver Excellent Growth From Core Products 32Shire Continues to Deliver Excellent Growth From Core Products 33Microlife-WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 2Microlife-WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 3
(Date:8/28/2014)... 2014 Millennium Treatment Group recently announced a ... large, and Millennium Treatment Group is working to close it, ... need. , According to the National Survey on Drug ... Americans could have benefited from treatment for drug and/or substance ... This means that there is a large treatment gap in ...
(Date:8/28/2014)... August 28, 2014 American adults who ... on the Internet will now have a simpler way ... In one click this year, some of the best ... http://quotespros.com/life-insurance.html . , The promoted plans that included ... finder tool represent popular policies. The term, guaranteed and ...
(Date:8/28/2014)... exit strategy from the war, now may be the time ... to veterans, says a Perspective piece in the New ... doing more of the same is to fail to recognize ... structure pose in the longer run," said William Weeks, from ... David Auerbach, from the RAND Corporation, in the August issue ...
(Date:8/28/2014)... MI (PRWEB) August 28, 2014 Biotronic, ... nation’s leading intraoperative neurophysiology monitoring ("IONM") company, today announced ... the position of Chief Executive Officer effective immediately. Mr. ... to President and CFO in 2013 and has been ... , “Bill’s efforts and achievements since joining the ...
(Date:8/28/2014)... Idaho (PRWEB) August 28, 2014 Kirklyn Smith, ... on what may be a new world’s record by walking ... desk.At TrekDesk we are constantly amazed by the thousands of ... but some just seem to stand out more than the ... daily 24 hour step count which tallies a range of ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:A VA exit strategy 2Health News:Biotronic NeuroNetwork Announces the Promotion of Bill Gecsey to CEO 2Health News:There are many reasons why Americans' exercise levels have declined - Meet an executive that refuses to sit still with his TrekDesk Treadmill Desk even in a sedentary job 2
... globalization visionOSAKA, Japan, March 30 ... announced a reorganization of its corporate structure, as ... become a global pharmaceutical company with highly integrated ... to rapid changes in the global operating environment ...
... The American Association of Oral and Maxillofacial ... Oral Health Rehabilitative Enhancement Act of 2009" (H.R. 1430 IH), ... referring their Medicare patients for physical therapy. Introduced on March ... (D-N.J.) and Congressman Eric Cantor (R-Va.), ...
... Introduced by the National Association of Boards ... Internet Pharmacy Practice Sites(TM) (VIPPS)(R) program celebrates 10 ... consumers to confidently access important information regarding the ... the nation. A total of 16 pharmacy sites ...
... Technologies, Inc., a developer of advanced visual prosthetic ... today announced the FDA Ophthalmic Devices Advisory Panel ... the premarket application (PMA) for its implantable telescope ... first medical device to be recommended by the ...
... UCSF research team has developed a technique to ... differences in levels of genetic markers. Standard ... and somewhat subjective, the researchers say, and supplementing ... to help clarify difficult-to-diagnose cases. , In a ...
... shows that people with multiple sclerosis may be at a ... of developing certain types of cancer, such as brain tumors ... 31, 2009, print issue of Neurology , the medical ... Researchers looked at the medical records of 20,000 people with ...
Cached Medicine News:Health News:Takeda to Create Global Centers of Excellence 2Health News:Takeda to Create Global Centers of Excellence 3Health News:Takeda to Create Global Centers of Excellence 4Health News:AAOMS Applauds Legislation Enabling Medicare Patients to Rehabilitate and Recover More Efficiently From Oral and Maxillofacial Injuries 2Health News:VIPPS Celebrates 10th Anniversary, Continues to Guide Consumers to Legitimate Internet Pharmacies 2Health News:VIPPS Celebrates 10th Anniversary, Continues to Guide Consumers to Legitimate Internet Pharmacies 3Health News:FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration 2Health News:FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration 3Health News:New strategy developed to diagnose melanoma 2Health News:New strategy developed to diagnose melanoma 3Health News:Multiple sclerosis associated with lower cancer risk 2
37°C incubator for DianaGel cards....
ScanGel® Incubator...
... The Mini-PROTEAN 3 Dodeca cell runs up ... in just 35 minutes. Handcast gels can ... the new Model 485 gradient former and ... variation and improving reproducibility. Alternatively, Ready Gel ...
... Mini-PROTEAN 3 Dodeca cell runs up to ... just 35 minutes. Handcast gels can be ... new Model 485 gradient former and Mini-PROTEAN ... and improving reproducibility. Alternatively, Ready Gel precast ...
Medicine Products: